Advertisement

The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The effect of combined phenformin-stanazolol therapy on blood lipids and fibrinolytic activity was studied in 20 patients with essential hypertriglyceridaemia. Statistically significant reduction of triglyceride and cholesterol levels and significant increase of blood fibrinolytic activity were seen in the course of treatment.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Glueck C.J.
        • Levy R.I.
        • Fredrickson D.S.
        Immunoreactive insulin, glucose tolerance and carbohydrate inducibility in types II, III, IV and V hyperlipoproteinemia.
        J. Amer. Diab. Ass. 1969; 18: 739
        • Ciświcka-Sznajderman M.
        Badania nad pierwotnymi hiperlipoproteidemiami.
        Pol. Arch. Med. Wewn. 1971; 46: 577
        • Spöttl F.
        • Holzknecht F.
        • Knapp E.
        • Steinmetz U.
        • Braunsteiner H.
        A basic study of the global coagulation and fibrinolysis of hyperlipemic and atherosclerotic patients.
        Atherosclerosis. 1970; 12: 427
        • Holzknecht F.
        • Spöttl F.
        • Knapp E.
        • Steinmetz U.
        • Braunsteiner H.
        A basic study of the global coagulation and fibrinolysis of hyperlipemic and atherosclerotic patients.
        Atherosclerosis. 1970; 12: 415
        • Fearnley G.R.
        • Chakrabarti R.
        • Evans J.F.
        Fibrinolytic and defibrinating effect of phenformin plus ethyloestrenol in vivo.
        Lancet. 1969; i: 910
        • Fearnley G.R.
        • Chakrabarti R.
        • Evans J.F.
        Effect of ethyloestrenol combined with phenformin or with metformin on platelet stickiness and serum-cholesterol in patients with occlusive vascular disease.
        Lancet. 1968; ii: 1004
        • Isacson S.
        • Nilsson I.M.
        Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic system.
        Scand. J. Haematol. 1970; 7: 404
        • Tzagournis M.
        • Seidensticker J.F.
        • Hamwi G.J.
        Metabolic abnormalities in premature coronary disease, effects of therapy.
        Ann. N. Y. Acad. Sci. 1968; 148: 945
        • Boshell B.R.
        • Chandalia H.B.
        • McAdams G.L.
        • Roddam R.F.
        Phenformin and insulin secretion.
        Post. Med. J. 1969; (Suppl. May): 38
        • Harsant P.R.
        A review of the mode of action of phenformin.
        Post. Med. J. 1969; (Suppl. May): 20
        • Kuo P.T.
        • Quick R.E.
        Improvement of hypertriglyceridemia by anabolic agent in primary type I hyperlipoproteinemia.
        Circulation. 1970; 42: 66
        • Sperry W.M.
        • Webb M.
        A revision of the Schoenheimer-Sperry method for cholesterol determination.
        J. Biol. Chem. 1950; 187: 97
        • Ignatowska H.
        Bezporednia metoda oznaczania trójglicerydów w surowicy krwi.
        Pol. Arch. Med. Wewn. 1964; 34: 273
        • Lees R.W.
        • Hatch F.T.
        Sharper separation of lipoprotein species by electrophoresis in albumin-containing buffer.
        J. Lab. Clin. Med. 1963; 61: 518
        • Niewiarowski S.
        Krzepniecie krwi. 1960; (PZWL): 150
        • Fearnley G.R.
        • Balmforth G.
        • Fearnley E.
        Evidence of diurnal fibrinolytic rhythm.
        Clin. Sci. 1957; 16: 645
        • Menon I.S.
        • Muscat-Baron J.
        • Weightman D.
        • Dewar H.A.
        The brain as contributor of plasminogen activator to the blood.
        Clin. Sci. 1970; 38: 85
        • Grace C.S.
        • Goldrick R.B.
        Fibrinolysis and body build.
        J. Atheroscler. Res. 1968; 8: 705
        • Fearnley G.R.
        • Chakrabarti R.
        • Evans J.F.
        Mode of action of phenformin plus ethyloestrenol on fibrinolysis.
        Lancet. 1971; i: 723
        • Epstein S.E.
        • Rosing D.R.
        • Brakman P.
        • Redwood D.R.
        • Astrup T.
        Impaired fibrinolytic response to exercise in patients with type IV hyperlipoproteinemia.
        Lancet. 1970; ii: 631
        • Spöttl F.
        • Holzknecht F.
        • Braunsteiner H.
        Inhibitors of the plasminogen activation in patients with primary carbohydrate-induced hypertriglyceridemia.
        J. Atheroscler Res. 1968; 8: 821
        • Spöttl F.
        • Holzknecht F.
        • Braunsteiner H.
        Enhancement of the fibrinolytic activity by venous occlusion in patients with primary carbohydrate-induced hypertriglyceridemia.
        Acta Haematol. 1969; 41: 154
        • Chakrabarti R.
        • Hocking E.D.
        • Fearnley G.R.
        • Mann R.D.
        • Attwell T.N.
        • Jackson D.
        Fibrinolytic activity and coronary artery disease.
        Lancet. 1968; i: 987
        • Ciświcka-Sznajderman M.
        • Młynski J.
        • Lotholc J.
        Czestość hiperlipoproteidemii u chorych z przebytym zawalem serca.
        Pol. Tyg. Lek. 1972; 2: 1673
        • Heinle R.A.
        • Levy R.J.
        • Fredrickson D.S.
        • Gorlick R.
        Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease.
        Amer. J. Cardiol. 1969; 24: 178
        • Skrzydlewski Z.
        • Niewiarowski S.
        Influence of plasma lipoproteins on the fibrinolytic activity.
        Thromb. Diath. Haemorrh. 1967; 17: 482